et al.. Comparison of two enzymatic immunoassays, high resolution mass spectrometry method and radioimmunoassay for the quantification of human plasma histamine. Journal of Pharmaceutical and Biomedical Analysis, Elsevier, 2016, 118, pp.ABSTRACT Histamine (HA) is one of the main immediate mediators involved in allergic reactions. HA plasma concentration is well correlated with the severity of vascular and respiratory signs of anaphylaxis. Consequently, plasma quantification of HA is useful to comfort the diagnosis of anaphylaxis. Currently, radioimmunoassay (RIA) is the gold standard method to quantify HA due to its high sensitivity, but it is time consuming, implicates specific formations and cautions for technicians, and produces hazardous radioactive wastes. The aim of this study was to compare two enzymatic immunoassays (EIA) and one in-house liquid chromatography high-resolution mass spectrometry method (LC-HRMS) with the gold standard method for HA quantification in plasma samples of patients suspected of anaphylaxis reactions. Ninetytwo plasma samples were tested with the 4 methods (RIA, 2 EIA and LC-HRMS) for HA quantification. Fifty-eight samples displayed HA concentrations above the positive cut-off of 10 nM evaluated by RIA, including 18 highly positive samples (> 100 nM). Our results showed that Immunotech ® EIA and LC-HRMS concentrations were highly correlated with RIA values, in particular for samples with a HA concentration around the positive cut-off. In our hands, plasma concentrations obtained with the Demeditec Diagnostics ® EIA correlated less with results obtained by RIA, and an underestimation of plasma HA levels led to a lack of sensitivity. In conclusion, this study demonstrates that Immunotech ® EIA and LC-HRMS method could be used instead of RIA to assess plasma HA in human diagnostic use.
Anaphylaxis is a potentially lethal systemic type I hypersensitivity reaction [1] . This lifethreatening emergency can lead very quickly to hypovolemia shock and cardiorespiratory arrest. In western countries, anaphylaxis incidence is estimated to be comprised between 4
and 50/100000 inhab/year with a prevalence of 0.05-2%. Emergency admission registers highlight a two fold increase of anaphylaxis prevalence during the last decades [2] .
After a first exposure to an allergen leading to high-affinity IgE synthesis by long-lived plasma cells, these IgE are predominantly found linked to the high-affinity IgE receptor (FcεRI) at the cell surface of mast cells and basophils. Following a second exposure to the same allergen, the cross-linking of the FcεRI leads to cell activation and the release within a few minutes of a huge amount of histamine (HA) contained in cell granules (10 -5 to 10 -3 mol/L) [3, 4] , as well as other preformed proinflammatory mediators [5] . HA or 2-(1Himidazol-4-yl) ethanamine is synthetized from L-histidine in the Golgi apparatus by the histidine decarboxylase [6] . Several cell types can synthetize HA in humans [7] ,but mast cells and basophils distinguish themselves by their ability to store HA in their granules, enabling a huge acute release of HA upon IgE cross-linking.
The anaphylaxis diagnosis is usually retained on a body of evidence. Suspicion is made primarily on clinical signs [8] [9] [10] . Currently, two biological parameters are commonly used to strengthen the diagnosis of anaphylaxis: serum tryptase and plasma HA. HA quantification is useful to confirm that clinical signs result from the degranulation of mast cells and/or basophils [11] . Physiologically, basal plasma HA amount is very low (<10nM) [8] but can increase very quickly and exponentially after mast cell or basophil degranulation.
Nevertheless, the HA protein half-life is extremely short [12] . Consequently, strict procedures of sampling for HA quantification are required: blood collection must be conducted within 15-60min after the beginning of the symptoms and plasma isolation has to be performed very quickly before conservation [13] . The production of highly specific monoclonal antibodies targeting HA is extremely challenging due to the nature of this small biogenic amine (M=111g.mol -1 ). The former quantification assays were based on the covalently binding of HA to a carrier protein on imidazole core or on NH2 end; nevertheless this chemical process was difficult to apply on plasma samples. Currently, classical HA quantification assays used for in vitro diagnosis (IVD) and based either on radioimmunoassay (RIA) [14] or enzymatic immunoassay (EIA) methods include an acylation step with NOH succinimide ester succinyl glycinamide, which turns HA into a bigger and more stable molecule that becomes easily detectable. Acylated plasma HA competes with exogenous acylated HA conjugated with a radioelement or an enzyme to bind a highly specific monoclonal antibody [15] . The current gold standard for HA quantification is RIA, it has the advantage of being highly sensitive [14] , but requires the use of radioactive reagents implying the formation and the follow up of the technicians, as well as the dangerous and expensive waste management. More recently, two EIA kits for IVD use, both avoiding the use of radioelements, have been commercialized by Immunotech ® and Demeditec Diagnostics ® . Finally, some methods using mass spectrometry have been developed to quantify plasma HA [16, 17] . In particular, our team developed an in-house plasma HA quantification assay for diagnostic use based on high Resolution Accurate Mass LC-MS (LC-HRMS) technology [18] . The LC-HRMS method is known to be highly sensitive and specific, averts radioactivity use, and avoids the potential detection of the metabolites of the targeted protein.
In this study, HA concentration was assessed in human plasma collected from patients with suspected anaphylactic reaction using three different methods: the gold standard RIA, the two commercialized EIA kits, and the in-house LC-HRMS-based method. This comparison reveals that Immunotech ® EIA and LC-HRMS are both sensitive enough methods to be considered as relevant non-radioactive alternative methods to RIA.
MATERIALS AND METHODS

Plasma samples
Plasmas collected between February 2010 and February 2014 in routine clinical practice by laboratories of Angers and Rennes University Hospitals from patients following a suspected anaphylaxis reaction were tested for HA quantification. The Ethical Review Board in Angers approved this study (2015/40). Peripheral blood was collected by venipuncture in EDTA tubes, and plasma was separated by centrifugation at 3000g for 10min. Thereafter, plasma was aspirated gently while respecting a safety margin of 1cm from the buffy coat in order to avoid contamination by white blood cells, aliquoted and immediately frozen at -20°C.
Radioimmunoassay
HA quantification by RIA was performed following manufacturer's instructions (Immunotech, Marseille, France). Briefly, immediately after thawing, HA contained in plasma samples was acylated. Then, plasma samples were incubated overnight within monoclonal antibody (mAb)-coated tubes in presence of a 125 I-labeled acylated HA internal tracer.
Following incubation, the contents of the tubes were aspirated and bound radioactivity was measured using a Cobra 2 auto gamma counter (Packard instrument, Meriden, CT, USA) .
Limits of quantification given by the manufacturer were 0.2-100nM. The limit for pathological values is 10nM.
Enzymatic immunoassays
HA quantification by EIA was performed following manufacturers' recommendations (Immunotech ® and Demeditec Diagnostics ® , Kiel, Germany). For both kits, samples were manipulated in polypropylene tubes and tested in duplicate.
For Immunotech ® EIA, HA was acylated by a first vortex step with an acylation reagent. respectively. The manufacturer gave no target range of concentration for the controls. Limits of quantification given by the manufacturer were 6.6-76.0nM.
High Resolution Accurate Mass LC-MS technology
A liquid chromatography coupled with an ultra-high resolution and accurate mass instrument was used to determine HA concentration. Briefly, 100μL of plasma was added to 250μL of de-ionized water and 100μL of internal standard Histamine-d4 (HAd4) (C/D/N isotopes, 
Statistical analysis
Sensitivity (Se), specificity (Sp), positive predictive value (PPV) and negative predictive value (NPV) of EIA and LC-HRMS were calculated and compared to RIA. A threshold of 10nM was used, because 10nM is considered the classical admitted limit for pathological values [8] , and corresponds to the cut-offs given by manufacturers for RIA and EIA kits. 
RESULTS AND DISCUSSION
Cohort recruitment and HA quantification by RIA
This study aimed to compare HA concentrations of human plasma samples from patients with suspected anaphylactic reaction quantified with several assays for in vitro diagnostic use. HA measurement for 34 samples (37%) was quantified below the threshold of 10nM by RIA, and was consequently considered negative in routine clinical practice. One of these 34 samples was quantified below 0.2nM corresponding to the RIA lower limit of detection. Fifty-eight samples (63%) were considered positive with HA concentration measured by RIA above 10nM, including 18 samples with a concentration above the RIA upper limit of quantification of 100nM. Globally, HA concentrations of our cohort of 92 samples were well distributed over the quantification range of the RIA. The RIA method remains the historical gold standard for HA quantification in biologic fluids since several decades. Despite its high sensitivity (analytical sensitivity: 0.2nM), this radioactive method displays several disadvantages, including the exposition risk of technicians to 125 I and the management of radioactive wastes. Furthermore, the use of the radioactive reagents restricted to a specific window of radioactive decay leads to peculiar ordering of reagents, increases the delay of reagent shipment, and consequently expands the waiting time of results for the patient. We selected 3 alternative assays using 2 different methods: Immunotech ® EIA, Demeditec
Diagnostics ® EIA and LC-HRMS (Table S1 ) [18, 19] . HA concentration values obtained by RIA were compared with the HA concentrations obtained with each of the other methods, based on a list of samples presenting a HA concentration in the detection limits of both tested methods.
Comparison of Immunotech ® EIA to RIA
HA concentration of the 92 tested samples was evaluated with RIA and Immunotech ® EIA.
Considering all samples, sensitivity of the Immunotech ® EIA method was 100% with no false negative, and the specificity was 59% ( figure 1A) . The Bland-Altman plot comparing Immunotech ® EIA to RIA values showed an estimated bias of 3.10nM (SD: 6.02nM; 95% limits of agreement: -8.69 -14.90nM) ( figure   1B ).
Because HA concentrations between 1 and 20nM could be arduous to interpret for clinicians [20] , a focus was made on samples displaying concentrations measured by RIA comprised in this range (n=47), and a Pearson's correlation coefficient of 0.88 (95% CI 0.80-0.93; p<0.0001) was calculated ( Figure 1C ). The subsequent Bland-Altman plot showed an estimated bias of +2.97nM (SD: 3.08nM; 95% limits of agreement: -3.07 -9.01nM) ( In conclusion, besides a slight overestimation of HA concentrations, all these observations support the hypothesis that EIA can be a favorable alternative to RIA, as described previously for other molecules like progesterone, cortisol, or infliximab [21] [22] [23] .
Comparison of Demeditec Diagnostics ® EIA to RIA
For the 92 plasma samples tested, no false positive were found resulted in 100% specificity for Demeditec Diagnostics EIA versus RIA. Nevertheless, 20 false negative values were observed leading to a sensitivity of 66% (table 1) .
Among the 91 samples within the detection limits of RIA, only 23 plasma samples (25%)
were between 6.66 and 76nM, the limits of detection of Demeditec Diagnostics ® EIA, and were further compared to RIA. The Pearson's correlation coefficient r calculated for the 23 samples was 0.45 (95% CI: 0.05-0.73; p=0.0311) ( figure 2A ). As shown in the Bland-Altman plot, HA quantification was underestimated with Demeditec Diagnostics ® EIA with a mean difference of -17.85nM (SD: 20.16nM; 95% limits of agreement: -57.36 -21.66nM) ( figure   2B ). Finally, only 4 samples quantified between 1 and 20nM by RIA were in the limits of quantification of Demeditec Diagnostics ® EIA kit, so it was not judicious to specifically focus on these samples.
In conclusion, in our hands, the use of Demeditec Diagnostics ® EIA resulted in an important proportion of false negative samples, which could be an obstacle for the diagnosis of anaphylaxis. A poor correlation with RIA values was obtained, despite excellent correlation coefficients obtained for the standard curves built with 5 standard dilutions (r>0.99).
Comparing Demeditec Diagnostics ® EIA, Immunotech ® EIA and RIA protocols, we noticed a longer acylation step for Demeditec Diagnostics ® EIA (45min versus an immediate acylation by vortexing for the 2 other assays). This could explain the important underestimation of HA quantification for the Demeditec Diagnostics ® EIA method, because it is well known that HA remains stable only after acylation.
Comparison of LC-HRMS to RIA
For the 92 plasma samples tested, LC-HRMS sensitivity was 93% with 4 false negatives, and specificity was 100% with no false positive. The PPV and NPV were 100% and 89%, respectively (table 1) . (table 2) . At this same range, Immunotech ® EIA was weakly correlated with a correlation coefficient of 0.88, was still very sensitive, but display many false positive results that could lead to overdiagnosis ( Figure 1C ).
Seventy
In conclusion, besides a slight underestimation of HA concentrations measured by LC-HRMS, LC-HRMS gave particularly encouraging results, as a good correlation with RIA was found [18] .
Comparison of the 3 tested assays to RIA
The 4 tested assays display similar characteristics with respect to their lower limit of quantification and their quantification range, except for the Demeditec Diagnostics ® EIA which display a lower limit of quantification (LLOQ) of 6.66nM, close to the positive threshold of 10nM. Our results highlight a very high sensitivity for Immunotech ® EIA and LC-HRMS (100% and 93%, respectively), in contrast to Demeditec Diagnostics ® EIA (66%).
This latter assay showed 20 false negative among the 58 samples considered as positive with a threshold of 10nM. Among these 20 false negative results, RIA quantified 3 of them as having a concentration higher than 70nM. Demeditec Diagnostics ® EIA and LC-HRMS showed a perfect specificity (1.00 for both), compared to RIA. A high number of false positives were found for Immunotech ® EIA (14 out of 72 positive samples), but the mean HA concentration of these samples was 11.91+/-1.40nM, which represent concentrations close to the positive threshold of 10nM.
It is well known that HA is very quickly metabolized in vivo by the histamine Nmethyltransferase (HNMT) and the diamine oxydase (DAO) with a short half-life estimated at 102 seconds (17) . A degradation of HA for a specific test can be rule out, as samples for each assay were aliquoted and frozen simultaneously. Thawing procedure in ice was also the same for the 4 assays. According to the manufacturers' data, cross-reactivity with the metabolite methyl histamine is estimated at 0.1% in Demeditec Diagnostics ® EIA, and cross-reactivity to acylated methyl histamine is estimated at 0.027%, and 0.069% in Immunotech ® EIA and RIA, respectively. LC-HRMS is the only assay that can distinguish methyl histamine from HA [16] [17] [18] . This could explain the trend of LC-HRMS to slightly underestimate plasma HA concentrations in comparison to RIA.
New cut-offs for Immunotech ® EIA and LC-HRMS assays
At the sight of statistical results obtained with Immunotech EIA and LC-HRMS method, we (table 3) .
CONCLUSION
Our results demonstrate that LC-HRMS and Immunotech ® EIA could be good alternatives to RIA for HA quantification in medical laboratories, after optimization of the sensitivity and the specificity of the two assays using new cut-offs (7.88 and 14.39nM for LC-HRMS and Immunotech® EIA, respectively). These two methods have the advantage to avoid the use of radioactivity with all its constraints. However, rare are the laboratories possessing a highresolution mass spectrometer due to the price of the instruments, and this could limit the development of HA quantification with LC-HRMS.
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